[1] World Health Organization. World Malaria Report 2015[R].Geneva:WHO,2015. [2] World Health Organization. Guidelines for the treatment of malaria(Third edition)[R]. Geneva:WHO,2015. [3] 赵绍敏,王满元. 恶性疟原虫对青蒿素类药物产生耐药性的全球现状和基础研究[J]. 中国寄生虫学与寄生虫病杂志,2014,32(5):81-85. [4] 纪晓光,孙雅洁,王京燕,等.青蒿化学成分及其与青蒿素伍用对鼠疟的药效学研究[J]. 寄生虫与昆虫学报,2008,15(4):198-201. [5] De-Oliveira AC,Da-Matta AC,Paumgartten FJ. Plasmodium berghei(ANKA):infection induces CYP2A5 and 2E1 while depressing other CYP isoforms in the mouse liver[J]. Experimental Parasitology,2006,113(4):256-261. [6] Weathers PJ,Arsenault PR,Covello PS,et al. Artemisinin production in Artemisia annua:studies in planta and results of a novel delivery method for treating malaria and other neglected diseases[J]. Phytochemistry Reviews,2011,10(2):173-183. [7] Abolaji AO,Eteng MU,Ebong PE,et al. A safety assessment of the antimalarial herb Artemisia annua during pregnancy in wistar rats[J]. Phytotherapy Research,2013,27(5):647-654. [8] World Health Organization. WHO position Statement: effectiveness of non-pharmaceutical forms of Artemisia annua L. against malaria[R].Geneva:WHO,2012. [9] 王满元,张超,李静,等. 青蒿截疟组合物与牛血清白蛋白的相互作用[J]. 高等学校化学学报,2014,35(2):309-313.